High-sensitivity C-reactive protein (hsCRP), procalcitonin (PCT), soluble urokinase-type plasminogen activator receptor (suPAR), soluble triggering receptor expressed on myeloid cells (sTREM), interleukin-6 (IL-6), and azurocidin (AZU 1) are biomarkers commonly used to assess sepsis severity and predict patient outcomes. Here, AZU1 is linked to Sepsis.